Simplex Trading
ENTX icon

Simplex Trading’s Entera Bio ENTX Stock Holding History

Simplex Trading’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Buy
+600
New +$751 ﹤0.01% 8815
2023
Q1 		– Sell
-3,400
Closed -$2K – 9287
2022
Q4 		$2K Buy
3,400
+100
+3% +$72 ﹤0.01% 8560
2022
Q3 		$3K Buy
+3,300
New +$4.98K ﹤0.01% 9071
2021
Q4 		– Sell
-19,200
Closed -$120K – 10703
2021
Q3 		$120K Buy
19,200
+500
+3% +$2.56K ﹤0.01% 6354
2021
Q2 		$111K Buy
+18,700
New +$69.1K ﹤0.01% 6573

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Simplex Trading's ENTX Position: Q2 2026 in Review

Simplex Trading opened a new position in Entera Bio (ENTX) in Q2 2026: 15,698 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #6820 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ENTX as recently as Q3 2025.

Simplex Trading first reported a position in ENTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $122K in Q3 2021. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Simplex Trading held 15,698 shares of Entera Bio worth $27.8K as of Q2 2026.
  • Entera Bio was a new Simplex Trading position in Q2 2026.
  • Entera Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6820 holding.
  • Simplex Trading first reported a position in Entera Bio in Q2 2021 and has held it in 10 quarters since.
  • Simplex Trading's Entera Bio position peaked at $122K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.